We have placed cookies on your computer to help make this website better. We use a Matomo Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by Matomo (e.g. deny use/opt-out).

The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 32 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 5,200 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

Innovation is at the heart of everything that we do. It’s the driving force behind new ideas and future therapies.

... Research & Development

For us, innovation goes beyond drug development. Our innovation is built on expert knowledge of disease-pathophysiology’s, understanding of the patient, the use of big data and state-of-the-art technologies such as devices that result in innovative solutions for the patients need.

... Strategy

Our R&D pipeline is a source of great excitement – we currently have several new drug candidates and technologies in different phases of development.

... Pipeline

Our key innovation area is pain.

... Focus area

Collaboration with the scientific community is central to our R&D strategy. Let’s work together – collaborate with us!

... Collaborate with us

Good business

Good business means taking responsibility for the communities and wider world around us.
We don’t just think about today but tomorrow too, acting with future generations in mind and doing all we can to minimize our impact on the environment.

As detailed in our Code of Conduct and Environment, Health & Safety policies, we work within occupational health and safety guidelines and comply with all relevant laws, internationally recognized guidelines and industry standards.

We are proud of every step we make, but are determined to do more. Beyond our overarching purpose – to improve the health of people around the globe, working with our customers and partners we want to create shared value through sustainability for our company and society as a whole.

Compliance

We observe high standards of integrity and honesty to ensure we follow our Code of Conduct.

... Learn more about Compliance at Grünenthal

A Heart for people

Imagine a world free of pain. We can – and we do all we can to make it a reality. Caring for the world around us is a big part of who we are – from a patient’s pain to climate change – we’re committed to doing what we can to tackle these issues, big and small.

... Read about our social commitment.